Company Filing History:
6 out of 1,743 
3 out of 141 
3 out of 5,076 
Years Active: 2010-2024
Title: The Innovative Contributions of Erwan Mortier
Introduction
Erwan Mortier is a notable inventor based in Nantes, France. He has made significant contributions to the field of biomedical research, particularly in the area of interleukin-15 (IL-15) and its applications in treating various diseases. With a total of seven patents to his name, Mortier's work has the potential to impact therapeutic strategies for autoimmune and inflammatory conditions.
Latest Patents
One of Mortier's latest patents involves the IL-15Rα sushi domain—IL-15 fusion proteins. This invention focuses on stimulating the IL-15Rbeta/gamma signaling pathway to induce the activation and proliferation of IL-15Rbeta/gamma-positive cells, such as NK and T cells. The appropriate compounds include those that comprise at least one IL-15Rbeta/gamma binding entity, which is covalently linked to a polypeptide containing the sushi domain of the extracellular region of an IL-15Ralpha. Another significant patent pertains to the uses of IL-15 antagonists for treating autoimmune and inflammatory diseases. This invention details an IL-15 mutant polypeptide with specific amino acid substitutions aimed at enhancing therapeutic efficacy.
Career Highlights
Throughout his career, Erwan Mortier has worked with prestigious institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the National Center for Scientific Research (Centre National De La Recherche Scientifique). His research has been pivotal in advancing our understanding of IL-15 and its role in immune responses.
Collaborations
Mortier has collaborated with esteemed colleagues, including Yannick Jacques and Ariane Plet. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Erwan Mortier's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His work on IL-15 and its therapeutic applications continues to pave the way for advancements in treating autoimmune and inflammatory diseases.